Holly E Richter1, Heather J Litman, Emily S Lukacz, Larry T Sirls, Leslie Rickey, Peggy Norton, Gary E Lemack, Stephen Kraus, Pamela Moalli, Mary Pat Fitzgerald, Kimberly J Dandreo, Liyuan Huang, John W Kusek. 1. From the University of Alabama at Birmingham, Birmingham, Alabama; New England Research Institute, Watertown, Massachusetts; the University of California San Diego, San Diego, California; William Beaumont Hospital, Royal Oak, Michigan; the University of Maryland, Baltimore, Maryland; the University of Utah, Salt Lake City, Utah; the University of Texas Southwestern, Dallas, Texas; University Texas San Antonio, San Antonio, Texas; Magee Women's Hospital, Pittsburgh, Pennsylvania; Loyola University, Maywood, Illinois; and the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Abstract
OBJECTIVE: To identify clinical and demographic factors predictive of midurethral sling failure. METHODS:Overall treatment failure was defined by one or more of the following objective outcomes: a positive stress test, positive 24-hour pad test or retreatment for stress urinary incontinence (SUI); subjective outcomes: self reported SUI by the Medical, Epidemiologic and Social Aspect of Aging questionnaire, incontinent episodes by 3-day diary, or retreatment for SUI, or a combination of these. Logistic regression models adjusting for sling type and clinical site were used to predict odds of overall treatment failure after univariable analysis. Models were also fit to compare factors associated with objective failure and subjective failure only. RESULTS:Previous UI surgery (odds ratio [OR] 1.99, 95% confidence interval [CI] 1.14-3.47); maximum Q-tip excursion<30° (OR 1.89, 95% CI 1.16-3.05); Medical, Epidemiologic and Social Aspect of Aging questionnaire urge score per 10 points (OR 1.97, 95% CI 1.21-3.21); and pad weight per 10 g (OR 1.06, 95% CI 1.02-1.10) were predictors of overall failure. Having concomitant surgery (OR 0.44, 95% CI 0.22-0.90) was predictive of subjective failure only rather than objective failure. Age per 10 years (OR 1.48, 95% CI 1.14-1.90); Urogenital Distress Inventory score per 10 points (OR 1.09, 95% CI 1.02-1.17); pad weight per 10 g (OR 1.05, 95% CI 1.01-1.10) were predictive of objective failure compared with subjective failure only. Associations of risk factors and failure were similar independent of sling type (retropubic or transobturator). CONCLUSION: Twelve months after surgery, risk factors for overall and objective treatment failure were similar in women undergoing retropubic and transobturator sling procedures. This information may assist in counseling patients regarding efficacy of sling procedures and in setting expectations for women at increased odds for treatment failure. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00325039. LEVEL OF EVIDENCE: II.
RCT Entities:
OBJECTIVE: To identify clinical and demographic factors predictive of midurethral sling failure. METHODS: Overall treatment failure was defined by one or more of the following objective outcomes: a positive stress test, positive 24-hour pad test or retreatment for stress urinary incontinence (SUI); subjective outcomes: self reported SUI by the Medical, Epidemiologic and Social Aspect of Aging questionnaire, incontinent episodes by 3-day diary, or retreatment for SUI, or a combination of these. Logistic regression models adjusting for sling type and clinical site were used to predict odds of overall treatment failure after univariable analysis. Models were also fit to compare factors associated with objective failure and subjective failure only. RESULTS: Previous UI surgery (odds ratio [OR] 1.99, 95% confidence interval [CI] 1.14-3.47); maximum Q-tip excursion<30° (OR 1.89, 95% CI 1.16-3.05); Medical, Epidemiologic and Social Aspect of Aging questionnaire urge score per 10 points (OR 1.97, 95% CI 1.21-3.21); and pad weight per 10 g (OR 1.06, 95% CI 1.02-1.10) were predictors of overall failure. Having concomitant surgery (OR 0.44, 95% CI 0.22-0.90) was predictive of subjective failure only rather than objective failure. Age per 10 years (OR 1.48, 95% CI 1.14-1.90); Urogenital Distress Inventory score per 10 points (OR 1.09, 95% CI 1.02-1.17); pad weight per 10 g (OR 1.05, 95% CI 1.01-1.10) were predictive of objective failure compared with subjective failure only. Associations of risk factors and failure were similar independent of sling type (retropubic or transobturator). CONCLUSION: Twelve months after surgery, risk factors for overall and objective treatment failure were similar in women undergoing retropubic and transobturator sling procedures. This information may assist in counseling patients regarding efficacy of sling procedures and in setting expectations for women at increased odds for treatment failure. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00325039. LEVEL OF EVIDENCE: II.
Authors: Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark Ellerkmann; Sandip Vasavada; Mark D Walters Journal: Am J Obstet Gynecol Date: 2008-12 Impact factor: 8.661
Authors: Yuko M Komesu; Holly E Richter; Darrell L Dinwiddie; Nazema Y Siddiqui; Vivian W Sung; Emily S Lukacz; Beri Ridgeway; Lily A Arya; Halina M Zyczynski; Rebecca G Rogers; Marie Gantz Journal: Int Urogynecol J Date: 2016-10-13 Impact factor: 2.894
Authors: Halina M Zyczynski; Leslie Rickey; Keisha Y Dyer; Tracey Wilson; Anne M Stoddard; E Ann Gormley; Yvonne Hsu; John W Kusek; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2012-06-29 Impact factor: 8.661
Authors: Holly E Richter; Linda Brubaker; Anne M Stoddard; Yan Xu; Halina M Zyczynski; Peggy Norton; Larry T Sirls; Stephen R Kraus; Toby C Chai; Philippe Zimmern; E Ann Gormley; John W Kusek; Michael E Albo Journal: J Urol Date: 2012-06-15 Impact factor: 7.450